207 related articles for article (PubMed ID: 16044579)
1. Relationship between lipoatrophy and quality of life.
Echavez M; Horstman W
AIDS Read; 2005 Jul; 15(7):369-75. PubMed ID: 16044579
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy and quality of life of HIV-infected persons.
Guaraldi G; Murri R; Orlando G; Squillace N; Stentarelli C; Zona S; Garlassi E; Martínez E
AIDS Rev; 2008; 10(3):152-61. PubMed ID: 18820717
[TBL] [Abstract][Full Text] [Related]
3. A comparison of lipoatrophy and aging: volume deficits in the face.
Coleman S; Saboeiro A; Sengelmann R
Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
[TBL] [Abstract][Full Text] [Related]
4. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment: correcting facial lipoatrophy has little to do with vanity.
Wohl DA
AIDS Read; 2005 Jul; 15(7):372. PubMed ID: 16044580
[No Abstract] [Full Text] [Related]
6. Restorative interventions for HIV facial lipoatrophy.
Carey D; Liew S; Emery S
AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
[TBL] [Abstract][Full Text] [Related]
8. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
[TBL] [Abstract][Full Text] [Related]
9. Surgical correction of HIV-associated facial lipoatrophy.
Guaraldi G; Fontdevila J; Christensen LH; Orlando G; Stentarelli C; Carli F; Zona S; de Santis G; Pedone A; De Fazio D; Bonucci P; Martínez E
AIDS; 2011 Jan; 25(1):1-12. PubMed ID: 20975513
[No Abstract] [Full Text] [Related]
10. The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.
Warde M; Gragnani A; Gomes H; Hochman B; Ferreira LM
Int J STD AIDS; 2011 Oct; 22(10):596-9. PubMed ID: 21998182
[TBL] [Abstract][Full Text] [Related]
11. Facial lipoatrophy: appearances are not deceiving.
Sanches RS; Mill J; Machado AA; Donadi EA; Morais Fernandes AP
J Assoc Nurses AIDS Care; 2009; 20(3):169-75. PubMed ID: 19427594
[TBL] [Abstract][Full Text] [Related]
12. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
[TBL] [Abstract][Full Text] [Related]
13. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated facial lipoatrophy.
James J; Carruthers A; Carruthers J
Dermatol Surg; 2002 Nov; 28(11):979-86. PubMed ID: 12460289
[TBL] [Abstract][Full Text] [Related]
15. Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): impact on the quality of life.
Quintas RC; de França ER; de Petribú KC; Ximenes RA; Quintas LF; Cavalcanti EL; Kitamura MA; Magalhães KA; Paiva KC; Filho DB
Int J Dermatol; 2014 Apr; 53(4):497-502. PubMed ID: 24602032
[TBL] [Abstract][Full Text] [Related]
16. Treatment of facial lipoatrophy via autologous fat transfer.
Cohen G; Treherne A
J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
[TBL] [Abstract][Full Text] [Related]
17. Management options for facial lipoatrophy.
Cofrancesco J; Brown T; Martins CR
AIDS Read; 2004 Dec; 14(12):639-40, 645-50. PubMed ID: 15619779
[TBL] [Abstract][Full Text] [Related]
18. Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
Doward LC; Dietz B; Wilburn J; McKenna SP; Bhor M; Rajagopalan R
AIDS Read; 2008 May; 18(5):242-6, 252-6, 262-4. PubMed ID: 18589480
[TBL] [Abstract][Full Text] [Related]
19. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.
Orentreich D; Leone AS
Dermatol Surg; 2004 Apr; 30(4 Pt 1):548-51. PubMed ID: 15056149
[TBL] [Abstract][Full Text] [Related]
20. Polyacrylamide gel treatment of antiretroviral therapy-induced facial lipoatrophy in HIV patients.
Mansor S; Breiting VB; Dahlstrøm K; Andersen AB; Andersen O; Christensen LH
Aesthetic Plast Surg; 2011 Oct; 35(5):709-16. PubMed ID: 21359981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
